Avanos Medical (AVNS) Equity Average (2013 - 2026)

Avanos Medical has disclosed Equity Average across 14 years of filings, most recently posting $780.2 million for Q1 2026.

• Equity Average for Q1 2026 came in at $780.2 million, up 110.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $780.2 million (up 110.74% YoY), and the FY2025 annual result was $339.6 million, down 40.28% from the prior year.
• Equity Average came in at $780.2 million for Q1 2026 at Avanos Medical, roughly flat from $778.1 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.6 billion in Q2 2022 to a low of -$314.9 million in Q2 2024.
• The 5-year median for Equity Average is $575.8 million (2023), against an average of $710.2 million.
• Across the five-year window, Equity Average slumped 518.66% in 2024 and soared 228.2% in 2025, its largest moves.
• Avanos Medical's Equity Average stood at $1.3 billion in 2022, then decreased by 3.77% to $1.2 billion in 2023, then tumbled by 54.01% to $565.4 million in 2024, then surged by 37.63% to $778.1 million in 2025, then climbed by 0.26% to $780.2 million in 2026.
• The last three Equity Average figures came in at $780.2 million (Q1 2026), $778.1 million (Q4 2025), and $373.0 million (Q3 2025), per Business Quant data.